Mode
Text Size
Log in / Sign up
N/A N=28 Supportive Care

Behavioral Medicine Intervention With Depressed Patients in a Community Health Center Setting

Depression

Enrolled (actual)
28
Serious AEs
0.0%
Results posted
Oct 2013
Primary outcome: Primary: Depression Severity (CEDS-10) — 18; 12 units on a scale — p=<.001

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Relaxation Response Resiliency Program for Depression (Behavioral)
Age
Adult, Older Adult · 21+ yrs
Sex
All
Sponsor
Massachusetts General Hospital
Primary completion
Apr 2010

Outcome Measures

OutcomeResultp-value
PRIMARY
Depression Severity (CEDS-10)
18; 12 <.001 sig
PRIMARY
Health Status (SF-12)
51; 49; 58; 58; 65; 61 <.001 sig
PRIMARY
Quality of Life (QOL-5)
56; 62 <.01 sig
PRIMARY
Satisfaction With Care (PSQ-18)
3.9; 3.8; 4.0; 3.7; 4.3; 4.1
SECONDARY
The Health Promoting Lifestyle Profile II (HPLP-II)
2.0; 2.4; 2.7; 2.7; 1.9; 2.2 <.01 sig

Summary

The linkage between the Massachusetts General Hospital (MGH)-Community Health Associates and the MGH-Benson Henry Institute for Mind-Body Medicine began in order to address the concern of providing affordable, easily accessible, culturally appropriate behavioral medicine interventions for low income patients served by MGH Community Health Centers, as well as the desire to demonstrate the efficacy and economics of these interventions. Since depression was such a prevalent issue among health center patients, with a significant impact on health care service utilization, it was decided to focus on offering Mind/Body services to this population first.

Eligibility Criteria

Inclusion Criteria

  • Patients 21 years of age or older
  • Diagnosis of depression
  • Currently being treated for depression with medications and/or psychological counseling through one of the MGH-HealthCare Centers.
  • Planning to continue using the health center as their main source of general medical services for the coming year.

Exclusion Criteria

  • History of bipolar disorder
  • Active substance abuse
  • History of psychosis
  • Severe cognitive dysfunction (MMSE ≤ 24)
  • Inability to speak English
  • We will not exclude patients on the basis of their religious preferences or practices.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01330420). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search